- Home
- FLGT vs GCMG Comparison
FLGT vs GCMG Comparison
Compare FLGT & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- GCMG
- Stock Information
- Founded
- FLGT 2011
- GCMG 1971
- Country
- FLGT United States
- GCMG United States
- Employees
- FLGT N/A
- GCMG N/A
- Industry
- FLGT Medical Specialities
- GCMG Finance/Investors Services
- Sector
- FLGT Health Care
- GCMG Finance
- Exchange
- FLGT Nasdaq
- GCMG Nasdaq
- Market Cap
- FLGT 587.3M
- GCMG 631.4M
- IPO Year
- FLGT 2016
- GCMG N/A
- Fundamental
- Price
- FLGT $21.88
- GCMG $12.88
- Analyst Decision
- FLGT Buy
- GCMG Buy
- Analyst Count
- FLGT 3
- GCMG 4
- Target Price
- FLGT $25.33
- GCMG $15.13
- AVG Volume (30 Days)
- FLGT 204.3K
- GCMG 457.8K
- Earning Date
- FLGT 11-07-2025
- GCMG 11-07-2025
- Dividend Yield
- FLGT N/A
- GCMG 3.42%
- EPS Growth
- FLGT N/A
- GCMG N/A
- EPS
- FLGT N/A
- GCMG 0.19
- Revenue
- FLGT $303,223,000.00
- GCMG $533,097,999.00
- Revenue This Year
- FLGT $15.19
- GCMG $4.88
- Revenue Next Year
- FLGT $10.58
- GCMG $11.78
- P/E Ratio
- FLGT N/A
- GCMG $69.29
- Revenue Growth
- FLGT 4.31
- GCMG 15.56
- 52 Week Low
- FLGT $14.57
- GCMG $10.74
- 52 Week High
- FLGT $23.56
- GCMG $14.48
- Technical
- Relative Strength Index (RSI)
- FLGT 56.24
- GCMG 57.85
- Support Level
- FLGT $21.50
- GCMG $12.63
- Resistance Level
- FLGT $22.37
- GCMG $12.98
- Average True Range (ATR)
- FLGT 0.53
- GCMG 0.19
- MACD
- FLGT -0.09
- GCMG -0.04
- Stochastic Oscillator
- FLGT 45.52
- GCMG 62.30
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.